Q3 2022: Layoffs Continue, Alzheimer’s Soars and Accelerated Approvals Fall

The third quarter of 2022 came to a close Friday, and a review of the quarter’s top news suggests many companies were facing the same issues. Among these overarching themes are job cuts, a shift in focus away from COVID-19, an unexpected boost in the Alzheimer’s research space and increased scrutiny of accelerated approvals by the FDA.